Topic resource collection
Approved comparison material connected to this topic.
1378 resourcesRead both sides
Here's the honest answer: most peptide stacks marketed as 'Wolverine protocols' or 'tissue regeneration stacks' rest on animal data that has never been replicated in controlled human trials. The compounds work. BPC-157 genuinely …
Semax Amidate (N-Acetyl-Semax) High. Acetyl group blocks aminopeptidase cleavage at N-terminus Moderate-to-high. Increased lipophilicity aids passive diffusion 4–6 hours intranasal Cognitive enhancement, focus, BDNF upregulation …
Dihexa HGF/c-Met receptor agonism → BDNF upregulation High (crosses passively) 0.5–5 mg/kg subcutaneous Alzheimer's models, TBI, stroke, aging Most potent BDNF pathway activator studied; small-molecule advantage for systemic dosi…
Amino acid length 43 residues 7 residues (fragment) TB-4 and TB4 are identical full-length sequences; TB-500 is a shortened synthetic analog Molecular weight ~4963 Da ~858 Da Weight difference confirms structural identity between…
The table below outlines the key mechanistic, pharmacokinetic, and application differences that define the semax amidate vs modafinil mechanism comparison: Primary Molecular Target BDNF upregulation via TrkB receptor activation D…
In Vitro (cell culture) Limited proteolysis. Serum-free media lack POP and ACE, minimal Ac-SDKP generation Not applicable. Add exogenous fragments if testing fragment activity None. Uptake depends on transporter expression, not p…
Animal models (rodent skeletal muscle studies) Accelerated muscle repair, increased satellite cell activation, enhanced protein synthesis Rodent metabolism differs from human; dosing not directly translatable; short study duratio…
TB-4 and TB4 aren't two different compounds competing for your attention. They're the exact same 43-amino-acid peptide sequence. The hyphen versus no-hyphen distinction exists purely in supplier nomenclature, not in molecular str…
Primary Mechanism Binds and sequesters myostatin (GDF-8), removing genetic brake on satellite cell activation and myofibrillar protein synthesis Direct activation of IGF-1 receptors on muscle tissue, increasing mTOR signaling and…
Choosing the right senolytic for an anti-aging stack depends on mechanism, tissue selectivity, and evidence base. FOXO4-DRI competes primarily with dasatinib + quercetin (D+Q) and high-dose fisetin. The three most studied senolyt…
GHRP-2 Acetate GHSR-1a (hypothalamic neurons) 0.7 nM 20–30 minutes Moderate. Partial override during first 60 minutes of pulse Optimal balance of receptor selectivity and GH pulse amplitude; acetate salt provides superior stabili…
MK-677 (Ibutamoren) 8–12kg lean mass gain (24-week rodent studies, scaled) 1.1kg lean mass gain (24-month human trial, elderly subjects) Yes. IGF-1 elevation confirmed Investigational (not FDA-approved) GHRP-2 680% increase in pu…
A 2014 study published in Molecular Medicine found that ARA-290 reduced inflammation markers by 40–60% in murine sepsis models within 24 hours of administration. Yet when the same research team moved to human trials in sarcoidosi…
IENFD (nerve fiber density) +60–78% restoration in diabetic neuropathy models (8–12 weeks) +10–20% improvement in T2D polyneuropathy (12 weeks); responder rate 28–35% Partial. Mechanism confirmed but magnitude reduced Translates …
KPV MC-1R agonism → NF-κB cytoplasmic retention Melanocortin-1 receptor Direct (prevents translocation) 50–60% reduction Minimal T-cell suppression Most selective innate immune modulator. Preserves adaptive responses α-MSH Broad …
AOD-9604 Stimulates hormone-sensitive lipase (HSL) to hydrolyze triglycerides into free fatty acids White adipose tissue (beta-3 adrenergic receptors) Increased lipolysis without glucose or IGF-1 changes; fat mobilization indepen…
Mechanism of Action Immune modulation via VPAC receptor activation; downregulates NF- B and pro-inflammatory cytokines; promotes Treg differentiation Protease inhibitor that blocks SARS-CoV-2 replication; used during acute infect…
Dissolution Medium Ethanol or saline with vortexing DMSO at ≤10mg/mL, gentle rotation, no heat DMSO prevents oxidation and achieves consistent bioavailability. Ethanol introduces 15–20% variability Storage Temperature 4°C refrige…
AHK-Cu Copper-peptide signaling + collagen synthesis + anti-inflammatory Dermal papilla, follicular keratinocytes, perifollicular matrix Requires consistent application. Effects reverse if discontinued; no DHT inhibition Multi-pa…
Preclinical (Rodent CCI Models) Lesion volume, apoptotic cell count, neurobehavioral testing (Morris water maze, rotarod) 2.5–5.0 mL/kg daily × 7–14 days 30 min–6 hours Strong. 22–35% lesion reduction, improved motor recovery by …